FREQUENT QUESTIONS

Am I suitable for intratumoural immunotherapy and/or cryoablation?

After carefully examining your clinical record with sonographic images, CT scan and/or NMR (nuclear magnetic resonance) you will be informed whether it’s possible or not to carry out the treatment depending on the number, size and location of the different tumours.

Normally more than 70-80% of cases are accepted for treatment.

How long does the immunotherapy last?
Normally treatment is undertaken over a 6 day period.
How much does this treatment cost?

The price is personalized for each patient according to whether there is cryoablation or not, the need for CT scans for intratumoral injection, hospital stay or not, etc.

The different medicines administered are highly expensive: Yerboy, Opdivo, Keytruda.

When will I know if the treatment has been successful or not?

Once diagnostic tests have been done: CT scan, NMR, blood analysis 30 and 90 days after treatment.

How does the immune system and cancer work?

Our immune system has various types of cell: the so-called effector T lymphocytes and the so-called regulator T lymphocytes (Tregs). The effector T lymphocytes are those that attack and destroy the foreign antigens in our body, whether they be bacterial, viral or tumour cells, but they need somehow to be authorized to attack by the regulator T lymphocytes (Tregs) and in cancer these authorizing lymphocytes are tricked by the tumoural microenvironment and don’t allow the effector T lymphocytes to attack.

The immunotherapeutic medicine reduces the number of these regulator T lymphocytes (Tregs) and moreover exposes their concealment of tumoural antigens.

Cancer is an very intelligent, sophisticated disease that “dupes” our immune system into believing that carcinogenic cells are healthy ones and therefore prevents them from being attacked and destroyed by T lymphocytes in our immune system. Cryoablation and intratumoural immunotherapy succeeds in revealing and overcoming this duping.